Effectors regulatory T cells in pregnancy (and autoimmunity?)

Expert Review of Clinical Immunology

Volumn 3, Issue 6, 2007, Pages 861-869

  Chaouat, Gérard ^a  

^a INSERM   (France)

Author keywords

Implantation; Pregnancy; Regulation; Regulatory T cells; Tolerance

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CHEMOKINE; ESTROGEN; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; PLACENTA EXTRACT; TRANSFORMING GROWTH FACTOR BETA;

ALLOIMMUNIZATION; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL SPECIFICITY; CELL TRANSPLANTATION; EXPERIMENTAL MODEL; HUMAN; LYMPHOCYTE TRANSFER; NATURAL KILLER T CELL; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SPONTANEOUS ABORTION; SUPPRESSOR CELL;

EID: 36248988562     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/1744666X.3.6.861     Document Type: Review

References (110)

1. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp. Soc. Exp. Biol. 7, 320-338 (1953).
2. Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 21(6), 903-914 (1971).
3. Baker PJ, Amsbaugh DF, Stashak PW, Caldes G, Prescott B. Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide. J. Immunol. 128(3), 1059-1062 (1982).
4. Gershon RK, Cohen P, Hencin R, Liebhaber SA. Suppressor T cells. J. Immunol. 108(3), 586-590 (1972).
5. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of materno foetal tolerance. Nat. Immunol. 7(3), 241-245 (2006).
6. Funakoshi N, Ohno T, Kanoh T et al. Ayglobulinemia in a pregnant woman. Tohoku J. Exp. Med. 149(4), 359-365 (1986).
7. Mattson R, Sulila P, Bernadotte F, Mattsson A. Allopregnancy in B-cell deprived C57/BL mice - an investigation focusing on the relationship between survival of the fetuses and anti-paternal immune activity of the mothers. Dev. Comp. Immunol. 12/1, 167-176 (1988).
8. Smith RN, Powell AE. The adoptive transfer of pregnancy-induced unresponsiveness to male skin grafts with thymus-dependent cells. J. Exp. Med. 146, 899-904 (1977).
9. Simpson E, Chandler P, Pole D. A model of T-cell unresponsiveness using the male-specific antigen, H-Y. Cell. Immunol. 2, 251-257 (1981).
10. Chaouat G, Voisin GA, Escalier D, Robert P. Facilitation reaction (enhancing antibobies and suppressor cells) and rejection reaction (sensitized cells) from the mother to the paternal antigens of the conceptus. Clin. Exp. Immunol. 35, 13-24 (1979).
11. Chaouat G, and Voisin GA. Regulatory T cell subpopulations in pregnancy. I. Evidence for suppressive activity of the early phase of MLR. J. Immunol. 122, 1383-1388 (1979).
12. Chaouat G, Voisin GA. Regulatory T cells in pregnancy. III. Comparison of early acting and late acting suppressor T cells in MLR: evidence for involvement of differential T-cell subsets. Immunology 44(2), 393-400 (1981).
13. Chaouat G, Voisin GA. Regulatory T cells in pregnancy. IV. Genetic characteristics and mode of action of early MLR suppressive T cell subpopulations. J. Immunol. 127(4), 1335-1339 (1981).
14. Chaouat G, Voisin GA. Regulatory T cells in pregnancy. V. Allopregnancy-induced T-cell-suppressor factor is H-2 restricted and bears Ia determinants. Cell. Immunol. 62(1), 186-195 (1981).
15. Chaouat G, Monnot P, Hoffmann M, Voisin GA. Regulatory T cells in pregnancy. VI. Evidence for T-cell-mediated suppression of CTL generation toward paternal alloantigens. Cell. Immunol. 68(2), 322-331 (1982).
16. Chaouat G, Chaffaux S, Voisin GA. Immuno-active products of placenta (I). J. Reprod. Immunol. 2, 127-136 (1980).
17. Kovithavongs T, Dossetor JB. Suppressor cells in human pregnancy. Transplant Proc. 10(4), 911-913 (1978).
18. Engleman EG, McMichael AJ, Batey ME, McDevitt HO. A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression. J. Exp. Med. 147(1), 137-146 (1978).
19. Engleman EG, McMichael AJ, McDevitt HO. Suppression of the mixed lymphocyte reaction in man by a soluble T-cell factor. Specificity of the factor for both responder and stimulator J. Exp. Med. 147(4), 1037-1046 (1978).
20. Clark DA, McDermott MR, Szewczuk MR. Impairment of host-versus-graft reaction in pregnant mice. II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with successful allogeneic pregnancy. Cell. Immunol. 52(1), 106-118(1980).
21. Clark DA, Chaput A, Tutton B. Active suppression of host versus graft reaction in pregnant mice. VII. Spontaneous abortion of CBA x DBA/2 foetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity. J. Immunol. 136, 1668-1771 (1986).
22. Clark DA, Slapsys R, Chaput A et al. Immunoregulatory molecules of trophoblast and decidual suppressor cell origin at the maternofetal interface. Am. J. Reprod. Immunol. Microbiol. 10(3), 100-104 (1986).
23. Clark DA, Flanders KC, Hirte H et al. Characterization of murine pregnancy decidua transforming growth factor β. I. Transforming growth factor β 2-like molecules of unusual molecular size released in bioactive form. Biol. Reprod. 52(6), 1380-1388 (1995).
24. Steinmetz M, Minard K, Horvath S et al. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature 300(5887), 35-42 (1982).
25. Hood L, Steinmetz M, Malissen B. Genes of the major histocompatibility complex of the mouse. Annu. Rev. Immunol. 1, 529-568 (1983).
26. Chaouat G, Mathieson BJ, Asofsky R. Regulatory mechanisms in the mixed lymphocyte reaction: evidence for the requirement of two T cells to interact in the generation of effective suppression. J. Immunol. 129(2), 502-508 (1982).
27. Munro A. The I-J paradox remains unsolved. Nature. 306(5943), 537-538 (1983).
28. Marx JL. Tracking the lost I-J suppressor region. Science 223(4636), 573-574 (1984).
29. Chaouat G, Liacopoulos J, Briffaux M, Liacopoulos P. Non specific suppressive activity from tumor cell lines used for hybridisation, and selection of subclones devoid of such activity. Immunology 54, 363-368 (1985).
30. Green DR, Webb DR Saying the 'S' word in public. Immunol. Today 14(11), 523-525 (1993).
31. Chaouat G, Kiger N, Wegmann TG. Vaccination against spontaneous abortion in mice. J. Reprod. Immunol. 8, 389-394 (1983).
32. Chaouat G, Kolb JP, Kiger N, Stanislawski M, Wegmann TG. Immunological concomitants of vaccination against abortion in mice. J. Immunol. 134, 1594-1598 (1985).
33. Chaouat G, Kiger N, Chaouat G, Kolb JP, Wegmann TG, Guenet JL. Immunogenetic studies of spontaneous abortion in mice. I. Preimmunisation of the mother with allogeneic spleen cells. J. Immunol. 134, 2966-2972 (1985).
34. Chaouat G, Clark DA, Wegmann TG. Genetics aspects of the CBA/J x DBA/2 J and B10 x B10.A models of murine spontaneous abortions and prevention by leukocyte immunisation. 18th RCOG Study Group. In: Early Pregnancy Loss. Mechanisms and Treatment. RCOG. Allen WR, Clark DA, Gill TJ 3rd, Mowbray JF, Robertson WR (Eds). RCOG Press, London, UK 89-105 (1988).
35. Kiger N, Chaouat G, Kolb JP, Weginann TG, Guenet JL. Immunogenetic studies of spontaneous abortion in mice. Preimmunization of females with allogeneic cells. J. Immunol. 134(5), 2966-2970 (1985).
36. Bobe P, Chaouat G, Stanislawski M, Kiger N. Immunogenetics of spontaneous abortion in mice. II. Antiabortive effects are independent of systemic regulatory mechanisms. Cell. Immunol. 98, 577-586 (1986).
37. Bobe P, Kiger N. Immunogenetic studies of spontaneous abortion in mice. III. Non-H-2 antigens and gestation. J. Immunogenet. 16(3), 223-231 (1989).
38. Clark DA, Chaouat G, Guenet JL, Kiger N. Local active suppression and successful vaccination against spontaneous abortion in CBA/J mice. J. Reprod. Immunol. 10(1), 79-85 (1987).
39. Wegmann TG. Fetal protection against abortion: is it immuno suppression or immuno stimulation? Ann. Immunol. Inst. Pasteur. 135D, 309-311 (1984).
40. Chaouat G, Menu E, Athanassakis I, Wegmann TG. Maternal T cells regulate placental size and fetal survival. Reg. Immunol. 1(3), 143-148 (1988).
41. Robertson SA, Mau VJ, Hudson SN, Tremellen KP. Cytokine leukocyte networks and the establishment of pregnancy. Am. J. Reprod. Immunol. 37, 438-443 (1997).
42. Robertson SA, O'Connell AC, Hudson SN, Seamark RF. Granulocyte-macrophage colony-stimulating factor (GM-CSF) targets myeloid leukocytes in the uterus during the post-mating inflammatory response in mice. J. Reprod. Immunol. 46(2), 131-154 (2000).
43. O'Leary S, Jasper MJ, Warnes GM, Armstrong DT, Robertson SA. Seminal plasma regulates endometrial cytokine expression, leukocyte recruitment and embryo development in the pig. Reproduction 128(2), 237-247 (2004).
44. Robertson SA. Seminal fluid signaling in the female reproductive tract: lessons from rodents and pigs. J. Anim. Sci. 85(Suppl. 13), E36-E44 (2007).
45. Wegmann TG, Lin H, Guilbert L, Mossman TH. Bidirectional cytokines interactions in the materno fetal relationship: successful allopregnancy is a Th2 phenomenon. Immunol. Today 14, 353-355 (1993).
46. Lin H, Mossmann TR, Guibert L, Tuntipopat S, Wegmnann TG. Synthesis of T helper-2 cytokines at the maternal fetal interface. J. Immunol. 151, 4562-4573 (1993).
47. Chaouat G, Assal Meliani A, Martal J et al. IL-10 prevents inflammatory cytokine-mediated foetal death and is inducible by tau interferon. J. Immunol. 152, 2411-2420 (1995).
48. Bell SC, Billington WD. Anti-fetal allo-antibody in the pregnant female. Immunol. Rev. 75, 5-30 (1983).
49. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161(1), 72-87 (1985).
50. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155(3), 1151-1164 (1995).
51. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609), 1057-1061 (2003).
52. + regulatory T cells. Nat. Immunol. 4(4), 330-336 (2003).
53. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5, 266-271 (2004).
54. Athanassakis I, Chaouat G, Wegmann TG. The effects of anti-CD4 and anti-CD8 antibody treatment on placental growth and function in allogeneic and syngeneic marine pregnancy. Cell. Immunol. 129(1), 13-21 (1990).
55. + regulatory/suppressor T cells prevent allogeneic fetus rejection in mice. Immunol. Lett. 102(1), 106-109 (2006).
56. Sulila P, Holmdahl R, Hansson I, Bernadotte F, Mattsson A, Mattsson R. An investigation of allogeneic pregnancy in multiparous mice subjected to in vivo depletion of CD8 (Ly2)-positive lymphocytes by monoclonal antibody treatment. J. Reprod. Immunol. 14/3, 235-245 (1988).
57. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 270(5236), 630-633 (1995).
58. Jiang SP, Vacchio MS. Multiple mechanisms of peripheral T cell tolerance to the foetal 'allograft'. J. Immunol. 160, 3086-3090 (1998).
59. Vacchio MS, Hodes RJ. Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy. J. Immunol. 174(8), 4657-4661 (2005).
60. Hunt JS, Vasmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158, 4122-4128 (1997).
61. Runic R, Lockwood CJ, Ma Y, Dipasquale B, Guller S. Expression of Fas ligand by human cytotrophoblasts: implication in placentation and fetal survival. J. Clin. Endocrinol. Metab. 81, 3119-3122 (1996).
62. Uckan D, Steele A, Chery BY et al. Trophoblasts express Fas ligand. A proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3, 655-662 (1997).
63. Chaouat G, Clark DA. FAS/FAS ligand interaction at the placental interface is not required for the success of allogeneic pregnancy in anti-paternal MHC preimmunized mice. Am. J. Reprod. Immunol. 2, 108-115 (2001).
64. Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281(5380), 1191-1193 (1998).
65. Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J. Reprod. Immunol. 52(1-2), 5-13 (2001).
66. Clark DA, Blois S, Kandil J, Handjiski B, Manuel J, Arch PC. Reduced uterine indoleamine 2,3-dioxygenase versus increased TH1/TH2 cytokine ratios as a basis for occult and clinical pregnancy failure in mice and humans. Am. J. Reprod. Immunol. 54(4), 203 (2005).
67. high regulatory T cells in human pregnancy. J. Reprod. Immunol. 65(2), 111-120 (2005).
68. Shigeru S, Akitoshi N, Subaru MH, Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J. Reprod. Immunol. (Epub ahead of print) (2007).
69. Saito S, Shiozaki A, Sasaki Y, Nakashima A, Shima T, Ito M. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin. Immunopathol. 29(2), 115-122 (2007).
70. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol. Hum. Reprod. 12(5), 301-308 (2006).
71. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 178(4), 2572-2578 (2007).
72. Kallikourdis M, Betz AG. Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus? PLoS ONE 2, e382 (2007).
73. + 'effector' regulatory T cells in the gravid uterus. Proc. Natl. Acad. Sci. USA 104(2), 594-599 (2007).
74. Jasper MJ, Tremellen KP, Robertson SA. Reduced expression of IL-6 and IL-1α mRNAs in secretory phase endometrium of women with recurrent miscarriage. J. Reprod. Immunol. 73(1), 74-84 (2007).
75. Robertson SA, Guerin LR, Bromfield JJ. Male seminal constituents activate expansion of the T regulatory cell pool in early pregnancy. Journal of Reproductive Immunology Banff conference on Reproductive Immunology, Banff Canada 15-18 November, 2006.
76. Delage G, Moreau J-F, Taupin J-L et al. In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum. Reprod. 10, 2483-2488 (1995).
77. Delage G, Moreau J-F, Taupin J-L et al. Abnormal endometrial reactivity to colony stimulating factor 1 and leukemia inhibitory factor dependent female infertility. Contracept. Fertil. Sex. 25, 711-716 (1997).
78. Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, LiI TC, Zhang X. The production of leukemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum. Reprod. 12, 569-574 (1997).
79. Giess R, Tanasescu I, Steck T, Sendtner M. Leukaemia inhibitory factor gene mutations in infertile women. Mol. Hum. Reprod. 6, 581-586 (1999).
80. Laird SM, Tuckerman EM, Li TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod. Biomed. Online 13(1), 13-23 (2006).
81. Kralickova M, Sima R, Vanecek T et al. Leukemia inhibitory factor gene mutations in the population of infertile women are not restricted to nulligravid patients. Eur. J. Obstet. Gynecol. Reprod. Biol. 127(2), 231-235 (2006).
82. + T regulatory cells prevents fetal rejection in a murine abortion model. Am. J. Pathol. 166(3), 811-822 (2005).
83. + T regulatory cells in murine pregnancy. J. Reprod. Immunol. 65(2), 101-110 (2005).
84. Zenclussen AC, Gerlof K, Zendussen ML et. al. Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur. J. Immunol. 36(1), 82-94 (2006).
85. Zenclussen AC. Regulatory T cells in pregnancy. Springer Semin. Immunopathol. 28(1), 31-39 (2006).
86. Schumacher A, Wollenberg I, Bertoja AZ et. al. Pregnancy-protective regulatory T cells act in an antigen-specific manner. 4th European Congress of Reproductive Immunology, Graz, Austria, 5-9 July, 56(1), 1-78 (2006) (Abstract 0109).
87. Schumacher A, Wafula PO, Teles A, Yagita H, Volk H-D, Zenclussen AC. IL-10 but not TGF-β is essential for the suppressor function of Treg cells in murine pregnancy. Am. J. Reprod. Immunol. 57(6), 379-496 (2007).
88. Fallon PG, Jolin HE, Smith P et al. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 17(1), 7-17 (2002).
89. White CA, Johansson M, Roberts CT, Ramsay AJ, Robertson SA. Effect of interleukin-10 null mutation on maternal immune response and reproductive outcome in mice. Biol. Reprod. 70(1), 123-131 (2004).
90. Robertson SA, Skinner RJ, Care AS. Essential role fur IL-10 in resistance to lipopolysaccharide-induced preterm labor in mice. J. Immunol. 177(7), 4888-4896 (2006).
91. Clark DA, Manuel J, Lee L, Chaouat G, Gorczynski RM, Levy GA. Ecology of danger-dependent cytokine-boosted spontaneous abortion in the CBA x DBA/ 2 mouse model. I. Synergistic effect of LPS and (TNF-α + IFN-γ) on pregnancy loss. Am. J. Reprod. Immunol. 52(6), 370-378 (2004).
92. Clark DA, Yu G, Arck PC, Levy GA, Gorczynski RM. MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am. J. Reprod. Immunol. 49(5), 297-307 (2003).
93. Clark DA, Coker R. Transforming growth factor-β (TGF-β). Int. J. Biochem. Cell. Biol. 30(3), 293-298 (1998).
94. Hamilton MS, Hamilton BL. Environmental influences on immunologically associated recurent spontaneous abortion in CBA/J mice. J. Reprod. Immunol. 11, 237-241 (1987).
95. Zenclussen AC, Blois S, Stumpo R et al. Murine abortion is associated with enhanced interleukin-6 levels at the feto-maternal interface. Cytokine 24(4), 150-160 (2003).
96. Chaouat G. Re: pregnancy-induced 'tolerance', and the involvement of T cells in this process. Eur. J. Immunol. 36(8), 2273-2275 (2006).
97. Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol. 136(2), 373-378 (2004).
98. Prieto GA, Rosenstein Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 118(1), 58-65 (2006).
99. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 84(2), 370-378 (2006).
100. Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int. Immunol. 19(3), 337-343 (2007).
101. + regulatory T cells by human placental trophoblasts. J. Immunol. 174(12), 7539-7547 (2005).
102. + regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc. Natl. Acad. Sci. USA 104(19), 8029-8034 (2007).
103. + T cells. J. Immunol. 177(11), 7645-7655 (2006).
104. + regulatory T cells and prevents experimental autoimmune encephalomyelitis. J. Immunol. 178(10), 6043-6050 (2007).
105. Zhang ZX, Ma Y, Wang H et al. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perfurin/ granzyme-dependent, Fas-Fas ligand-independent pathway. J. Immunol. 177(10), 6920-6929 (2006).
106. Thomson CW, Lee BP, Zhang L. Double-negative regulatory T cells: non-conventional regulators. Immunol. Res. 35(1-2), 163-178 (2006).
107. Ford MS, Chen W, Wong S et al. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development. Eur. J. Immunol. 37(8), 2234-2241 (2007).
108. + T cells with natural suppressor activity. J. Reprod. Immunol. 21(2), 103-125 (1992).
109. Offner H, Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci. 1089, 343-372 (2006).
110. Huan J, Culbertson N, Spencer L et al. Decreased FOXP3 levels in multiple sclerosis patients. J. Neurosci. Res. 81(1), 45-52 (2005).